Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01630733
Title A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
Recruitment Unknown status
Gender both
Phase Phase III
Variant Requirements No
Sponsors OncoGenex Technologies
Indications

lung non-small cell carcinoma

Therapies

Docetaxel

Custirsen + Docetaxel

Age Groups: adult
Covered Countries USA | ITA | ESP | DEU


No variant requirements are available.